Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04171635 · ClinicalTrials.gov registry record
Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 55
- Enrollment target
NCT04171635 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 55 participants.
The verdict
NCT04171635 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The overall goal of this research is to help develop a new magnetic resonance (MR) method, Quantitative Susceptibility Mapping (QSM), to improve the measurement of liver iron concentrations without the need for a liver biopsy. Measurement of liver iron is important to diagnose and treat patients who have too much iron in their bodies (iron overload). Liver iron measurements by current MRI methods (R2 and R2\*) can be inaccurate because of the effects of fat, fibrosis and other abnormalities. QSM should not be affected by these factors and should be free of these errors. In this study, MRI measurements (QSM, R2 and R2\*) of iron in patients before liver transplant will be compared with chemical analysis of iron in liver explants (livers removed from patients undergoing liver transplant). The liver explants would otherwise be discarded. Investigators expect that this study will show that the new MRI method, QSM, is superior to the current MRI methods, R2 and R2\*.
Interventions
- RADIATION Quantitative Susceptibility Mapping (QSM) Magnetic Resonance Imaging (MRI)
- RADIATION R2* Magnetic Resonance Imaging (MRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04171635
The ClinicalTrials.gov registry entry for NCT04171635 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quantitative Susceptibility Mapping (QSM) Magnetic Resonance Imaging (MRI) is the first listed.
NCT04171635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04171635 about?
NCT04171635 is a clinical study titled "Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy". The overall goal of this research is to help develop a new magnetic resonance (MR) method, Quantitative Susceptibility Mapping (QSM), to improve the measurement of liver iron concentrations without the need for a liver biopsy. Measurement of liver iron is important to diagnose and treat patients who...
What is the current status of trial NCT04171635?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2019-12-16. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT04171635?
The interventions under investigation include: Quantitative Susceptibility Mapping (QSM) Magnetic Resonance Imaging (MRI) (RADIATION), R2* Magnetic Resonance Imaging (MRI) (RADIATION).
Who is sponsoring clinical trial NCT04171635?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.